Group 2 of 66 patients: 1 single injection on Day 1 and 91, 4 sites, 3 doses, 1 placebo.
Hair counts at 12 months since last injection.
Note the inclusion criteria is male pattern baldness. The initial Phase I/IIa trails were almost 50/50, male/female. Second, RCI-02 is to be completed in 2014; hopefully they use their updated device. Third, they extended the waiting period from 6 months to 12 month from injection.The Phase I/IIa check may be due to the original mouse study which also checked at 6 months.
I have not seen anything regarding Sheseido trails, but I don't know Japanese either. The only statement to note is rather vague and general.
We will establish the Shiseido Cell-Processing and Expansion Center in Kobe in May and use this facility as a base for related research and development aimed at future commercialization. It is expected to be some time before this innovation makes a profit. However, we expect it to be very profitable and create value and new markets in the future.
I guess we will see in 2-3 years...

Leave a comment: